Michael Kelly
Vorstandsvorsitzender bei NERVGEN PHARMA CORP.
Vermögen: 889 226 $ am 30.04.2024
Aktive Positionen von Michael Kelly
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ARS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.05.2019 | - |
Independent Dir/Board Member | 01.05.2019 | - | |
NERVGEN PHARMA CORP. | Direktor/Vorstandsmitglied | 10.04.2023 | - |
Vorstandsvorsitzender | 10.04.2023 | - | |
Präsident | 10.04.2023 | - | |
ARS Subsidiary, Inc.
ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology ARS Pharmaceuticals, Inc. develops epinephrine nasal sprays for treatment of severe allergic reactions to food, medication, and insect bites. The company was founded by Richard E. Lowenthal, Sarina Tanimoto and Robert Bell and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | 01.05.2019 | - |
Karriereverlauf von Michael Kelly
Ehemalige bekannte Positionen von Michael Kelly
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Emergent Devices, Inc.
Emergent Devices, Inc. Pharmaceuticals: MajorHealth Technology Part of Emergent BioSolutions, Inc., Emergent Devices, Inc. is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Plymouth Meeting, PA. | Geschäftsführer | 01.03.2016 | 01.06.2019 |
Covis Pharmaceuticals, Inc.
Covis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Covis Pharmaceuticals, Inc. specializes and distributes pharmaceutical products. It is a specialty pharmaceutical distributor dedicated to improving the lives of people with life-threatening conditions and chronic illnesses. The company was founded on November 2, 2011 and is headquartered in Chesterbrook, PA. | Direktor/Vorstandsmitglied | 01.12.2013 | 01.03.2016 |
Vorstandsvorsitzender | 01.12.2013 | 01.03.2016 | |
Präsident | 01.12.2013 | 01.03.2016 | |
Azur Pharma Ltd.
Azur Pharma Ltd. Pharmaceuticals: MajorHealth Technology Azur Pharma Ltd. manufactures pharmaceutical products. It offers branded generic prescription drugs, antibiotics and medicines in multiple therapeutic areas. The company was founded in May, 2005 and is headquartered in Dublin, IE | Corporate Officer/Principal | - | 27.01.2012 |
Jazz Pharmaceuticals Commercial Corp.
Jazz Pharmaceuticals Commercial Corp. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals Commercial Corp. provides pharmaceutical services. It engages in identifying, developing, and commercializing products in the areas of CNS, women's health, and urology. The company was founded in 2005 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | 07.12.2010 | 01.01.2012 |
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Geschäftsführer | - | 03.10.2005 |
Viropharma, Inc. | Vertrieb & Marketing | - | - |
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Michael Kelly
The College of New Jersey | Undergraduate Degree |
Rider University | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 10 |
Irland | 3 |
Kanada | 2 |
Operativ
Director/Board Member | 4 |
Corporate Officer/Principal | 3 |
Sales & Marketing | 2 |
Sektoral
Health Technology | 10 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
JAZZ PHARMACEUTICALS PLC | Health Technology |
NERVGEN PHARMA CORP. | Health Technology |
ARS PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 7 |
---|---|
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Health Technology |
Azur Pharma Ltd.
Azur Pharma Ltd. Pharmaceuticals: MajorHealth Technology Azur Pharma Ltd. manufactures pharmaceutical products. It offers branded generic prescription drugs, antibiotics and medicines in multiple therapeutic areas. The company was founded in May, 2005 and is headquartered in Dublin, IE | Health Technology |
Jazz Pharmaceuticals Commercial Corp.
Jazz Pharmaceuticals Commercial Corp. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals Commercial Corp. provides pharmaceutical services. It engages in identifying, developing, and commercializing products in the areas of CNS, women's health, and urology. The company was founded in 2005 and is headquartered in Philadelphia, PA. | Health Technology |
Covis Pharmaceuticals, Inc.
Covis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Covis Pharmaceuticals, Inc. specializes and distributes pharmaceutical products. It is a specialty pharmaceutical distributor dedicated to improving the lives of people with life-threatening conditions and chronic illnesses. The company was founded on November 2, 2011 and is headquartered in Chesterbrook, PA. | Health Technology |
ARS Subsidiary, Inc.
ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology ARS Pharmaceuticals, Inc. develops epinephrine nasal sprays for treatment of severe allergic reactions to food, medication, and insect bites. The company was founded by Richard E. Lowenthal, Sarina Tanimoto and Robert Bell and is headquartered in San Diego, CA. | Health Technology |
Emergent Devices, Inc.
Emergent Devices, Inc. Pharmaceuticals: MajorHealth Technology Part of Emergent BioSolutions, Inc., Emergent Devices, Inc. is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Plymouth Meeting, PA. | Health Technology |
Viropharma, Inc. |
- Börse
- Insiders
- Michael Kelly
- Erfahrung